Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,524
Sort by:
Global Teleradiology Market Size study, by Imaging Techniques (X-Ray, Computed Tomography (CT), Ultrasounds, Magnetic Resonance Imaging (MRI), Nuclear Imaging, Fluoroscopy, Mammography, Others), by Technology (Hardware, Software, Telecom & Networking), by End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others) and Regional Forecasts 2020-2027
US$ 3,750.00
Global Teleradiology Market is valued approximately USD 3.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 14% over the forecast period 2020-2027. Teleradiology is...
May 2020
200 pages
Impact of COVID-19 on Composites Market Size study, by Fiber Type (Glass Fiber, Carbon Fiber, Natural Fiber, and Others), Resin Type (Thermoset, and Thermoplastic), by End-Use Industry (Aerospace & Defense, Wind Energy, Transportation, Construction & Infrastructure, Marine, Pipes & Tanks, Electricals & Electronics, and Others) and Regional Forecasts 2020-2026
US$ 3,750.00
Impact of COVID-19 on Composites Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. A comp...
May 2020
200 pages
Impact of COVID 19 on Global Feed Market Size study, by Application (Poultry, Swine, and Aquaculture), Ingredient & Additive Type (Amino Acids, Phosphates, Vitamins, Minerals, Commodity Ingredients, Phytogenic, and Probiotics) and Regional Forecasts 2020-2026
US$ 3,750.00
Impact of COVID 19 on Global Feed Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Growi...
May 2020
200 pages
Anesthesia Machinery Market by Product (Continuous Anesthesia Machinery and Intermittent Anesthesia Machinery), Subject (Human and Veterinary), Application (Nervous System Surgeries, Respiratory System Surgeries, Musculoskeletal System Surgeries, Cardiovascular System Surgeries, Digestive System Surgeries, Urinary System Surgeries, and ENT System Surgeries), End User (Hospitals, Point Of Care, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The anesthetic machinery market was valued at $2,001.6 million in 2018, and is estimated to reach $3,288.0 million by 2026, registering a CAGR of 6.3% during the analysis period The anesthetic machine...
May 2020
132 pages
Anti-Viral Therapies Market by Type (Generic Drugs and Branded Drugs), Application (HIV, Hepatitis, Herpes Virus, Influenza, and Other Applications), and Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026
US$ 5,370.00
The global anti-viral therapies market was valued at $38,316.5 million in 2018, and is projected to reach $46,213.4 million by 2026 registering a CAGR of 2.4% from 2019 to 2026. Antiviral drugs belong...
May 2020
238 pages
Asia-Pacific Oncology Molecular Diagnostics Market by Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer & Others), End User (Hospitals, Reference Laboratories, & Others), Country (Australia, Vietnam, Thailand, Philippines & Rest of Asia-Pacific): Regional Opportunity Analysis and Industry Forecast, 2019–2026
US$ 4,850.00
The Asia Pacific oncology molecular diagnostics market was valued at $381.84 million in 2018 and is projected to reach $732.05 million by 2026, registering a CAGR of 9.0% from 2019 to 2026. Molecular...
May 2020
158 pages
Biosensors Market by Product (Wearable biosensors and Non- Wearable biosensors), Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, and Nanomechanical Biosensors): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global biosensors market was valued at $17,500.0 million in 2018, and is expected to reach $38,600.2 million by 2026, registering a CAGR of 10.4% from 2019 to 2026. Biosensors are medical devices...
May 2020
163 pages
Clinical Nutrition Market by Route of Administration (Oral, Enteral, and Parenteral), Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others), and End User (Pediatric, Adults, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2019-2026
US$ 5,370.00
The global clinical nutrition market size was valued at $313.578 billion in 2018, and is projected to reach $552.503 billion by 2026, growing at a CAGR of 5.3% from 2019-2026. Clinical nutrition produ...
May 2020
-
Diphtheria, Pertussis, and Tetanus (DTP) Vaccine Market by Product Type (DTaP vaccine (Diphtheria-Tetanus-acellular Pertussis vaccine), TD (Tetanus and Diphtheria) vaccine, and Tdap (Tetanus-Diphtheria-Acellular Pertussis) vaccine, by Age Group (Adult and Pediatric), and by End User (Hospitals, Clinics, and Vaccination Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,370.00
The global diphtheria, pertussis, and tetanus (DTP) vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% during the forecast p...
May 2020
193 pages
Global Thermoluminescent Dosimeter (TLD) Services Market by Type (Calcium fluoride TLD and Lithium fluoride TLD), Industry (Nuclear, Medical, Research institutions, Safety & Security Industries, Health Physics Applications, and Mining), Dosimetry Service (Whole-body X-ray Badges, Extremity Dosimetry, Environmental/Area Dosimetry, and Other services): Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global thermoluminescent dosimeter (TLD) services market was valued at $405.9 million in 2018, and is projected to reach $1335.9 million by 2026, registering a CAGR of 17.1% from 2019 to 2026. A t...
May 2020
215 pages
LATAM laboratory Equipment and Disposables Market By Product (Equipment (Incubators, Laminar Flow Hood, Micro Manipulation Systems, Centrifuges, Lab Air Filtration System, Scopes, Sonicators & Homogenizers, Autoclave & Sterilizers, Spectrophotometers & Microarray Equipment, Bioreactors, snd Others); Disposables (Pipettes, Tips, Tubes, Cuvettes, Dishes, Gloves, Mask, Cell Imaging Consumables, and Cell Culture Consumables), and End User (Academic Institutes, Clinical Diagnostic Centers, Forensics Industry, and Others): Opportunity Analysis and Industry Forecast, 2020–2027
US$ 3,390.00
The LATAM laboratory equipment and disposables market was valued at $1,759 million in 2019, and is projected to reach $2,831 million by 2027, registering a CAGR of 6.1% from 2020 to 2027. Laboratory i...
May 2020
205 pages
Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global neurostimulation devices market was valued at $4,387.5 million in 2018 and is projected to reach $11,257.4 million by 2026, registering a CAGR of 12.5% from 2019 to 2026. Neurostimulation i...
May 2020
176 pages
Neutropenia Treatment Market by Treatment (Colony-stimulating factors, Antibiotics, Antifungals, and Antivirals), and Distribution Channel (Hospital Pharmacies , Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,370.00
The global neutropenia treatment market was valued at $12,602.5 million in 2019, and is expected to reach $19,303.1 million by 2027, with a CAGR of 5.4% during the forecast period. Neutropenia refers...
May 2020
210 pages
Orthopedic Devices Market by Product (Drill Guide, Guide Tubes, Implant Holder, Custom Clamps, Distracters, and Screw Drivers), Application (Hip Orthopedic Devices, Knee Orthopedic Devices, Spine Orthopedic Devices, Craniomaxillofacial Orthopedic Devices, Dental Orthopedic Devices, and Sports Injuries and Extremities and Trauma Orthopedic Devices): Global Opportunity Analysis and Industry Forecast, 2019-2026
US$ 5,370.00
The global orthopedic devices orthopedic market was valued at $37.2 billion in 2018 and is expected to reach $47.7 billion by 2026, registering a CAGR of 3.1% from 2019 to 2026. Orthopedic devices can...
May 2020
243 pages
Wound Management Devices Market by Product (Therapy Devices, Wound closure Devices, and Others), Application (Burns, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, and Others), and End User (Hospitals, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global wound management devices market was valued at $13,396.8 million in 2018 and is projected to reach $18,818.4 million by 2026, registering a CAGR of 4.3% from 2019 to 2026. Wounds are one of...
May 2020
240 pages
Epidermolysis Bullosa - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Epidermolysis Bullosa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Epidermolysis Bullosa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
154 pages
Hepatitis A - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis A (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
33 pages
Narcolepsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Narcolepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
86 pages
Acne Vulgaris - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acne Vulgaris (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
224 pages
Allergic Rhinitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
164 pages
Angina (Angina Pectoris) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
78 pages
Atherosclerosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
245 pages
Bone Metastasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bone Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bone Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
127 pages
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
276 pages
Endometriosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
148 pages
Essential Thrombocythemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Essential Thrombocythemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Essential Thrombocythemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
115 pages
Fallopian Tube Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Fallopian Tube Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Fallopian Tube Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
1496 pages
Head And Neck Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... . The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
2943 pages
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Idiopathic Pulmonary Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
503 pages
Kidney Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Kidney Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
174 pages
Measles - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Measles (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Measles and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
43 pages
Osteoarthritis Pain - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Osteoarthritis Pain - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Osteoarthritis Pain (Central Nervous System), complete with analysis by stage of development ...
April 2020
245 pages
Osteoporosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
353 pages
Parkinson's Disease - Pipeline Review, H1 2020
US$ 2,500.00
... . The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
1201 pages
Peanut Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peanut Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
158 pages
Premature Ejaculation - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
41 pages
Rotavirus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
55 pages
Stroke - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
716 pages
Asthma - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
758 pages
Overactive Bladder - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
127 pages
Ulcerative Colitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
671 pages
Allergic Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
97 pages
Bronchiectasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bronchiectasis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
90 pages
